U.S. company Purdue Pharma files for Chapter 11 bankruptcy. Agreeing to contribute more than US$3 billion from the sale of a daughter company, the owners propose to settle thousands of lawsuits related to the risk of addiction to their narcotic painkiller Oxycontin.
